Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

794 indexed citations
published 2001

Countries where authors are citing Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

Specialization
Citations

This map shows the geographic impact of Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer more than expected).

Fields of papers citing Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

About Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

This paper, published in 2001, received 794 indexed citations . Written by Jos Jonkers, Ralph Meuwissen, Hanneke van der Gulden, Hans Peterse, Martin van der Valk and Anton Berns covering the research area of Genetics, Molecular Biology and Oncology. It is primarily cited by scholars working on Molecular Biology (535 citations), Oncology (411 citations) and Cancer Research (168 citations). Published in Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/ng747.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026